Page 12 - Clinical Programs News Today

Key Developments and Financial Highlights for Investors

The writings of the Covenant School shooter are disturbing and can bring back painful memories of that day. One mental health expert discusses how the writings can bring back painful memories.

Propel Bio Partners invests in companies that improve the quality of life for those with medical conditions, empowering startups with a patient-centric focus for market success.

PHILADELPHIA, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Passage Bio, Inc. (NASDAQ: PASG), a clinical stage genetic medicines company focused on developing transformative therapies for central nervous system (CNS) disorders, today announced that William Chou, M.D., president and chief executive officer, will participate in a fireside chat at Guggenheim’s 5th Annual Inflammation, Neurology & Immunology Conference on Monday, November 6, 2023 at 2:30 p.m. ET. A live webcast of the event will be ...

Coverage from The US Oncology Network Payer Transformation Summit, held September 27-29, 2023, in Atlanta, Georgia.

FOR IMMEDIATE RELEASE SPARC to Provide Update on Clinical Programs and R&D Pipeline MUMBAI, October 19, 2023, Sun...

HCA Healthcare to Offer GRAIL's Galleri® Multi-Cancer Early Detection (MCED) Test; HCA Healthcare's Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal HCA Healthcare, Inc.

HCA Healthcare to Offer GRAIL’s Galleri® Multi-Cancer Early Detection Test; HCA Healthcare’s Cancer Institute, Sarah Cannon, to Support Individuals Who Receive a Positive Signal ...

Danielle Griggs, PharmD, has been appointed as the Chief Pharmacy Officer of UVA Health, with responsibility for more than 500 employees and four hospitals in Virginia.

In addition to the annual flu vaccines, COVID-19 boosters and RSV vaccines present new opportunities for pharmacists to advise patients.